RhumbLine Advisers’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Sell |
446
-30
| -6% | -$941 | ﹤0.01% | 3832 |
|
|
2025
Q1 | $14.1K | Buy |
476
+61
| +15% | +$1.81K | ﹤0.01% | 3786 |
|
|
2024
Q4 | $12.2K | Hold |
415
| – | – | ﹤0.01% | 3858 |
|
|
2024
Q3 | $12.9K | Buy |
415
+60
| +17% | +$1.87K | ﹤0.01% | 3861 |
|
|
2024
Q2 | $12K | Buy |
355
+171
| +93% | +$5.79K | ﹤0.01% | 3952 |
|
|
2024
Q1 | $12K | Buy |
184
+128
| +229% | +$8.32K | ﹤0.01% | 3835 |
|
|
2023
Q4 | $3.82K | Buy |
56
+10
| +22% | +$683 | ﹤0.01% | 4022 |
|
|
2023
Q3 | $2.39K | Hold |
46
| – | – | ﹤0.01% | 4093 |
|
|
2023
Q2 | $2.76K | Buy |
+46
| New | +$2.76K | ﹤0.01% | 4173 |
|